Accipio Ix (discontinued)

MaxQ AI, Ltd.

**In January 2022 MaxQ announced the discontinuation of their imaging AI product portfolio.**
AccipioIx is a software workflow tool designed to aid in prioritizing the clinical assessment of adult non-contrast head CT cases with features suggestive of acute intracranial hemorrhage in the acute care environment. AccipioIx analyzes cases using an artificial intelligence algorithm to identify suspected findings. It makes case-level output available to a PACS/workstation for worklist prioritization or triage.
Product specifications Information source: Vendor
Last updated: Jan. 21, 2022
Product name Accipio Ix (discontinued)
Company MaxQ AI, Ltd.
Subspeciality Neuro
Modality CT
Disease targeted Intracranial hemorrhage
Key-features Per-case detection of ICH
Suggested use Before: adapting worklist order
Data characteristics
Population Stroke and head trauma patients suspicion of intracranial hemorrhage
Input Adult non-contrast head CT
Input format DICOM
Output Triage with notification
Output format DICOM Secondary Capture
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time
Certified, Class IIb , MDD
510(k) cleared, Class II
Market presence
On market since 05-2018
Distribution channels GE, Philips, FujiFilm, IBM, Nuance, Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers